Vehviläinen, Sini http://orcid.org/0000-0002-4892-1867
Kuuliala, Antti
Udd, Marianne
Nurmi, Anna
Peltola, Katriina
Haglund, Caj
Kylänpää, Leena
Seppänen, Hanna
Funding for this research was provided by:
University of Helsinki
Article History
Received: 5 April 2023
Accepted: 6 December 2023
First Online: 28 December 2023
Disclosures
: Sini Vehviläinen, Antti Kuuliala, Marianne Udd, Anna Nurmi, Caj Haglund, Leena Kylänpää, and Hanna Seppänen have no conflict of interests or financial ties to disclose. Katriina Peltola has received advisory fees from Ipsen, MSD, BMS, Roche and Astellas, and owns stocks from Faron Pharmaceuticals.